Latest Announcements

Aditya Birla Fashion and Retail Limited has informed BSE about the completion of the tenure of a Non-Executive Independent Director.

Skybiotech Healthcare Ltd has submitted its unaudited financial results for the half year ended on 30th September 2026, as per Regulation 33 of SEBI (LODR) Regulations, 2015. The results were approved by the Board of Directors at their meeting held on 10th November 2026.

Dredging Corporation of India Limited has informed the Exchange regarding a press release dated November 10, 2026, titled "DCIL Delivers Remarkable Strong Q2 Profitability Turnaround; EBITDA Rises 58.58% Year-on-Year".

Waterbase Ltd has announced its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The Board of Directors has approved the financial results, which will be available on the company's website and the stock exchange website. The auditor's report is attached, and the company will publish an extract of the consolidated financial results in newspapers within the stipulated time.

Virinchi Ltd's board meeting outcome for the quarter and half year ended September 30, 2026, includes the approval of unaudited financial results and the issuance of up to 2,00,00,000 convertible equity warrants to certain identified promoter and non-promoter entities.

Dredging Corporation of India Ltd has announced its financial results for the period ending 31st October, 2026. The company's profitability has improved, with a profit before tax of Rs. 5.8 crores and a profit after tax of Rs. 5.7 crores. The company's net sales have increased by 18.4% and its profit margins have improved. The company has also stated that its financial performance has been affected by the challenging market conditions and the impact of the COVID-19 pandemic.

Aditya Birla Fashion and Retail Ltd has announced the completion of the second term of Mr. Sunirmal Talukdar as an Independent Director of the Company.

Skybiotech Healthcare Ltd has submitted its unaudited financial results for the quarter and half year ended 30th September 2026. The results were approved by the Board of Directors at their meeting held on 10th November 2026.

Granules India Limited has informed the Exchange about the schedule of an Analyst/Investor Meeting to be held on November 16, 2026, at Mumbai. The meeting is part of the company's annual investor conference. The company has assured that no unpublished price-sensitive information will be shared during the meeting.

Midwest Ltd has submitted a statement of deviation or variation for the quarter ended September 30, 2026, stating that there are no deviations or variations in the utilization of IPO proceeds.

Maxgrow India Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/11/2026 to consider and approve unaudited financial results for September 2026.

Jubilant Pharmova Limited announced that clinical results from its Phase 1/2 study of JBI-802, a first-in-class oral dual inhibitor of LSD1 and HDAC6, have been selected for an oral presentation at the 68th ASH Annual Meeting.

Waterbase Ltd's board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The auditor's report on the financial results is attached. The company will publish an extract of the consolidated financial results in newspapers and make the detailed results available on its website.

Granules India Ltd has announced a schedule of investor meet on November 16, 2026, at Mumbai. The meeting will be attended by the company's management, analysts, and investors. The company has stated that no unpublished price-sensitive information will be shared during the meeting.

Jubilant Pharmova Ltd announced the selection of its Phase 1/2 study of JBI-802, a first-in-class oral dual inhibitor of LSD1 and HDAC6, for an oral presentation at the 68th American Society of Hematology (ASH) Annual Meeting. The study showed encouraging early evidence of rapid platelet reductions and hematologic control in patients with essential thrombocythemia and related myeloproliferative neoplasms.

Om Metallogic Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/11/2026 to consider and approve Standalone & Consolidated unaudited Financial Results for Half Year ended on 30th September, 2026.

AIK Pipes and Polymers Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 to consider and approve the Un-Audited Financial Results of the company for the half year ended 30th September, 2026 and to take on record Limited Review Report thereon.

Scintilla Commercial & Credit Ltd has scheduled a Board Meeting on 13/11/2026 to consider and approve unaudited financial results for the quarter and half year ended 30.09.2026.

Unicommerce Esolutions Limited has informed the Exchange about Schedule of meet for Analyst/Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.

MMTC Ltd has announced the change in management with the cessation of Shri Ajay Kumar Misra as Company Secretary and Compliance Officer and the appointment of Ms. Rashmi Chaddha as the new Company Secretary and Compliance Officer, effective from November 10, 2026.